The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2008 by North Shore Long Island Jewish Health System.
Recruitment status was Recruiting

Sponsor:

Information provided by:

North Shore Long Island Jewish Health System

ClinicalTrials.gov Identifier:

NCT00665613

First received: April 22, 2008

Last updated: April 23, 2008

Last verified: April 2008

History of Changes

Purpose

The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.

Condition
Osteoporosis

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Retrospective
Official Title:	The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Resource links provided by NLM:

MedlinePlus related topics: Blood Thinners Osteoporosis

Drug Information available for: Warfarin Warfarin sodium

U.S. FDA Resources

Further study details as provided by North Shore Long Island Jewish Health System:

Estimated Enrollment:	3000
Study Start Date:	October 2004

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

patients on warfarintherapy in the SIUH coumadin center

Criteria

Inclusion Criteria:

Patients on warfarin that have had BMD within a year

Exclusion Criteria:

Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00665613

Contacts

Contact: Mario Castellanos, MD

7182269000

mcastellanos@siuh.edu

Locations

United States, New York
Staten Island University Hospital	Recruiting
Staten Island, New York, United States, 10305
Contact: Mario Castellanos, MD 718-226-9000 mcastellanos@siuh.edu
Principal Investigator: Mario Castellanos, MD

Sponsors and Collaborators

Staten Island University Hospital

More Information

No publications provided

Responsible Party:	Mario Castellanos, MD, staten island hospital irb
ClinicalTrials.gov Identifier:	NCT00665613 History of Changes
Other Study ID Numbers:	04-054
Study First Received:	April 22, 2008
Last Updated:	April 23, 2008
Health Authority:	United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:

warfarin use

Additional relevant MeSH terms:

Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Warfarin

Anticoagulants
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 22, 2013

To Top